Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety Study of TA-7284 in Patients With Type 2 Diabetes

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Men or women age ≥20 years old~* Diagnosed with Type 2 diabetes mellitus at least 3 months before run-in period~* HbA1c of ≥7.0% and ≤10.0%~Exclusion Criteria:~* Type I diabetes mellitus, diabetes mellitus resulting from pancreatic disorder, secondary diabetes mellitus~* Past or current history of severe diabetic complications~* Fasting plasma glucose \> 270 mg/dL before treatment start~* History of hereditary glucose-galactose malabsorption or primary renal glucosuria~* Patients requiring insulin therapy

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- TA-7284 Low (Type: EXPERIMENTAL): None
- TA-7284 High (Type: EXPERIMENTAL): None
- Placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).